Reynders McVeigh Capital Management’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,055	Closed	-$201K	–	199
2024 Q1	$201K	Buy	+6,055	New	+$189K	0.01%	194
2023 Q3	–	Sell	-10,996	Closed	-$351K	–	195
2023 Q2	$351K	Sell	10,996 -46,560	-81%	-$1.51M	0.02%	165
2023 Q1	$1.76M	Sell	57,556 -12,227	-18%	-$483K	0.12%	74
2022 Q4	$2.73M	Sell	69,783 -5,131	-7%	-$230K	0.2%	64
2022 Q3	$3.57M	Buy	74,914 +7,039	+10%	+$402K	0.28%	56
2022 Q2	$2.63M	Sell	67,875 -15,389	-18%	-$612K	0.2%	61
2022 Q1	$4.77M	Buy	83,264 +4,136	+5%	+$271K	0.29%	51
2021 Q4	$6.31M	Buy	79,128 +6,330	+9%	+$542K	0.36%	46
2021 Q3	$6.33M	Buy	72,798 +1,693	+2%	+$170K	0.39%	46
2021 Q2	$9.15M	Buy	71,105 +3,653	+5%	+$291K	0.56%	44
2021 Q1	$5.4M	Sell	67,452 -1,237	-2%	-$118K	0.36%	46
2020 Q4	$5.61M	Buy	68,689 +9,828	+17%	+$483K	0.38%	45
2020 Q3	$1.45M	Buy	+58,861	New	+$1.46M	0.11%	83